CAS: 376584-63-3; (1H-Pyrazol-3-yl)Boronic Acid

该化合物是一种有机有机体化合物,其特点是存在一个阳极环和一种碳酸功能组,该化合物一般显示白色到白晶线外的表面,并且溶于水和酒精等极地溶剂,由于它们能够形成氢结,这是卤酸的一种常见特征.该化合物的富酸性能和功能性多变性使得它能够形成可逆的共价结合,与二醇形成可逆的共价结合,使其在各种应用中有用,包括有机合成和药用化学.它可以参与铃木-宫和木柳的交叉反应,促进碳结.此外,该聚星环有助于该化合物的潜在生物活动,因为聚氨酸衍生物因其药理特性而经常被探究.该化合物的再活性和功能性使其在合成更复杂的分子中成为有价值的中间体.适当的处理和储存由于其对水分和空气的敏感性,因而对其稳定性和再活动产生影响.

结构式图片

相似化合物

844501-71-9 1217500-54-3 1163248-54-1

欧盟法规

C&L通报

上下游产品

1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole Trimethyl borate[2-(1H-pyrazol-3-yl)benzyl]carbamic acid tert-butyl ester 5-phenyl-1H-pyrazole 4-methyl-2-(2H-pyrazol-3-yl)-thiazole-5-carboxylic acid benzylamide N-(4-fluoro-2-(1H-pyrazol-5-yl)benzyl)-3-(benzyloxy)-9,9-dimethyl-4-oxo-4,6,7,9-tetrahydropyrimido[2,1-c][1,4]oxazine-2-carboxamide

合成工艺路线路线简述

    专利信息


    专利号:US-9951088-B2
    优先权日:2012-05-09
    标题 :D2 receptor modulators and methods of use thereof in the treatment of diseases and disorders
    发明人:JONES PHILIP G; LEW ROBERT; SPEAR KERRY L; XIE LINGHONG
    权利人:SUNOVION PHARMACEUTICALS INC
    摘要:Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and neurological disorders, including, but not limited to, e.g., psychosis, schizophrenia, depression, movement disorders, and Parkinson's disease.

    专利号:WO-2011050245-A1
    优先权日:2009-10-23
    标 题:Bicyclic heteroaryls as kinase inhibitors
    发明人:FENG YANGBO; CHEN YEN TING; SESSIONS HAMPTON; MISHRA JITENDRA K; CHOWDHURY SARWAT; YIN YAN; LOGRASSO PHILIP; LUO JUN-LI; BANNISTER THOMAS; SCHROETER THOMAS
    权利人:FENG YANGBO; CHEN YEN TING; SESSIONS HAMPTON; MISHRA JITENDRA K; CHOWDHURY SARWAT; YIN YAN; LOGRASSO PHILIP; LUO JUN-LI; BANNISTER THOMAS; SCHROETER THOMAS
    摘要:The invention is directed to heteroaryl compounds useful as inhibitors of various kinase enzymes. In various embodiments, the invention provides a heteroaryl compound having inhibitory bioactivity with respect to a Rho kinase, an AKT kinase, a p70S6K kinase, a LIM kinase, an IKK kinase, a Flt kinase, an Aurora kinase, or a Src kinase, or any combination thereof. Compounds of the invention include bicyclic heteroaryl compounds of formula (I), which can contain a bridging nitrogen atom at a ring junction. The invention further provides methods of synthesis of compounds of the invention, pharmaceutical compositions, pharmaceutical combinations, and methods of treatment of malconditions using compounds of the invention.

    专利号:US-8633204-B2
    优先权日:2006-09-15
    标 题 :4-methylpyridopyrimidinone compounds
    发明人:CHENG HENGMIAO; BHUMRALKAR DILIP; DRESS KLAUS RUPRECHT; HOFFMAN JACQUI ELIZABETH; JOHNSON MARY CATHERINE; KANIA ROBERT STEVEN; LE PHUONG THI QUY; NAMBU MITCHELL DAVID; PAIRISH MASON ALAN; PLEWE MICHAEL BRUNO; TRAN KHANH TUAN
    权利人:CHENG HENGMIAO; BHUMRALKAR DILIP; DRESS KLAUS RUPRECHT; HOFFMAN JACQUI ELIZABETH; JOHNSON MARY CATHERINE; KANIA ROBERT STEVEN; LE PHUONG THI QUY; NAMBU MITCHELL DAVID; PAIRISH MASON ALAN; PLEWE MICHAEL BRUNO; TRAN KHANH TUAN; PFIZER
    摘要:The present invention is directed to novel 4-methylpyridopyrimidinone compounds of Formula (I), n nand to salts thereof, their synthesis, and their use as inhibitors of phosphoinositide 3-kinase alpha (PI3-Kα).

    专利号:US-9533996-B2
    优先权日:2012-06-18
    标 题 :Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones
    发明人:BRANSTETTER BRYAN; BREITENBUCHER JAMES; DYCK BRIAN; GOMEZ LAURENT; HUDSON ANDREW RICHARD; MARRONE TAMI JO; PETERS MARCO; VICKERS TROY; WEINHOUSE MICHAEL
    权利人:DART NEUROSCIENCE (CAYMAN) LTD
    摘要:Described herein are compounds of Formula I and Formula II, methods of their synthesis, compositions comprising the compounds, and use of the compounds and compositions in treating numerous diseases and disorders, including cognitive deficits associated with CNS diseases and disorders.

    专利号:WO-2010001220-A1
    优先权日:2008-07-01
    标 题 :New 1,2,4-triazine derivatives and biological applications thereof
    发明人:DESROY NICOLAS; DENIS ALEXIS; GERUSZ VINCENT; OLIVEIRA CHRYSTELLE; VONGSOUTHI VANIDA; MOREAU FRANCOISE; ESCAICH SONIA
    权利人:MUTABILIS SA; DESROY NICOLAS; DENIS ALEXIS; GERUSZ VINCENT; OLIVEIRA CHRYSTELLE; VONGSOUTHI VANIDA; MOREAU FRANCOISE; ESCAICH SONIA
    摘要:The invention relates to new 1,2,4-triazine derivatives of formula (I): wherein A, B, R2 and Y are defined in the application, their preparation and intermediates, their use as drugs and pharmaceutical compositions and associations containing them. The compounds of formula (I) are capable of inhibiting bacterial heptose synthesis.

    专利号:CN-117603193-A
    优先权日:2023-12-20
    标题:A kind of synthesis method of β-cyanopyrazole compounds
    北京普瑞东方化学技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bjpurechem.com
    企业联系电话:010-83993285👤
    📞北京普瑞东方化学技术有限公司 ⚠️参考联系方式
    联系人:冷先生
    电话:010-83993285
    手机:17610176018
    传真:010-63370219
    邮箱:sales@bjpurechem.com
    通信地址: 北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
    邮编: 100048
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海睿耘化学技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.rychemical.com.cn
    企业联系电话:021-67267633👤
    📞上海睿耘化学技术有限公司 ⚠️参考联系方式
    联系人:王清春
    电话:021-67267633
    手机:13917251563
    传真:021-67267655
    邮箱:sales@rychemical.com.cn
    通信地址: 金山区亭林镇松隐南星村3106号1楼46室
    邮编: 201512
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:金山区亭林镇松隐南星村3106号1楼46室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00044-023-03092-0
    摘要:Gupta M, Canziani G, Ang C, Mohammadi M, Abrams CF, Yang D, Smith AB, Chaiken I. Pharmacophore variants of the macrocyclic peptide triazole inactivator of HIV-1 Env. Med Chem Res. 2023 Jun 27;32(7):1497–509. doi: 10.1007/s00044-023-03092-0.
    参考文献:10.1007/s00044-024-03245-9
    摘要:Zhang Y, Dai L, Tan Y, Yu Y, Xing J, Yang F, Ren B, Xu Y, Li Q. Design and synthesis of novel factor XIa Inhibitors with bicyclic isoquinoline and naphthalene fragments. Med Chem Res. 2024 May 30;33(6):1003–23. doi: 10.1007/s00044-024-03245-9.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知